A 6-month randomised controlled trial to evaluate the impact of text message support on symptom control and inhaler adherence for patients with asthma and/or COPD
This trial will be a 6-month prospective, randomised controlled trial in which the study population is randomly allocated (1:1) to an intervention or control group. The trial is multicentre and is non-blind. All patients in both groups will continue to receive their usual care for the duration of the study. Randomisation will be at the individual level. Participants will be randomly allocated as per a computer-generated randomisation list using a random number generator as part of the Microsoft .NET framework. This is a behavioural intervention. The intervention will consist of a series of supportive text messages to patients from their GP practice over a 6 month period. The messages will vary in frequency from 2 or 3 in the first weeks of the trial to only 1 or 2 a month in the final months of the trial. The content of the messages will vary; some will contain information about how to use a preventer inhaler, some will emphasise the importance of using it, and some will provide simple reminders to patients to take their inhaler. All participants will continue to receive their usual care throughout the duration of the study; the text message intervention with be in addition to their usual care.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
6,053
The intervention group will receive a series of supportive text messages over the 6 month trial period, varying in content and frequency.
University Medical Centre
Canterbury, Kent, United Kingdom
Gravesend Medical Centre
Gravesend, Kent, United Kingdom
Jubilee Medical Centre
Longfield, Kent, United Kingdom
Marlowe Park Medical Centre
Rochester, Kent, United Kingdom
Improved self-reported medication taking as measured by the The Medication Adherence Report Scale (MARS-5) Questionnaire
Changes in the MARS-5 Questionnaire
Time frame: Baseline to 13 and 26 weeks
Improved control of asthma symptoms as measured by the Asthma Control Test
Changes in the Asthma Control Test
Time frame: Baseline to 13 and 26 weeks (for asthma patients)
A reduction in the interval between patients requesting preventer inhaler prescriptions
Reduction in days between consecutive preventer inhaler prescription requests
Time frame: Baseline to 13 and 26 weeks
Difference in emergency admissions
Differences in the number of emergency admissions between the intervention and control group
Time frame: Over 26 weeks
Differences in NHS utilisation
Differences in the utilisation of NHS resources between the intervention and control group
Time frame: Over 26 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
High Oak Surgery
Dudley, West Midlands, United Kingdom
Lion Health
Stourbridge, West Midlands, United Kingdom
Wordsley Green Health Centre
Worsley, West Midlands, United Kingdom